{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:45:45Z","timestamp":1791359145244,"version":"4.3.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,6]]},"DOI":"10.7759\/cureus.106527","type":"journal-article","created":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T14:36:56Z","timestamp":1775486216000},"source":"Crossref","is-referenced-by-count":1,"title":["Association of Peripheral Inflammatory Indices With Symptom Severity, Functioning, and Metabolic Parameters in the Mexican Population Diagnosed With Schizophrenia"],"prefix":"10.7759","author":[{"given":"H\u00e9ctor","family":"Guzm\u00e1n-Gonz\u00e1lez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Bernal-Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Morales-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauricio","family":"Rosel-Vales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/epirev\/mxn001","article-title":"Schizophrenia: a concise overview of incidence, prevalence, and mortality","volume":"30","author":"McGrath J","year":"2008","unstructured":"McGrath J, Saha S, Chant D, Welham J. Schizophrenia: a concise overview of incidence, prevalence, and mortality. Epidemiol Rev. 2008, 30:67-76. 10.1093\/epirev\/mxn001","journal-title":"Epidemiol Rev"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-025-00667-6","article-title":"Schizophrenia","volume":"11","author":"Leucht S","year":"2025","unstructured":"Leucht S, Siafis S, McGrath JJ, et al.. Schizophrenia. Nat Rev Dis Primers. 2025, 11:83. 10.1038\/s41572-025-00667-6","journal-title":"Nat Rev Dis Primers"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.47626\/1516-4446-2023-3126","article-title":"Treatment resistance in schizophrenia: a meta-analysis of prevalence and correlates","volume":"45","author":"Diniz E","year":"2023","unstructured":"Diniz E, Fonseca L, Rocha D, et al.. Treatment resistance in schizophrenia: a meta-analysis of prevalence and correlates. Braz J Psychiatry. 2023, 45:448-58. 10.47626\/1516-4446-2023-3126","journal-title":"Braz J Psychiatry"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.18502\/ijaai.v18i3.1119","article-title":"Alteration of serum levels of cytokines in schizophrenic patients before and after treatment with risperidone","volume":"18","author":"Azizi E","year":"2019","unstructured":"Azizi E, Zavaran Hosseini A, Soudi S, Noorbala AA. Alteration of serum levels of cytokines in schizophrenic patients before and after treatment with risperidone. Iran J Allergy Asthma Immunol. 2019, 18:262-8. 10.18502\/ijaai.v18i3.1119","journal-title":"Iran J Allergy Asthma Immunol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2021.11.014","article-title":"Peripheral complement is increased in schizophrenia and inversely related to cortical thickness","volume":"101","author":"Ji E","year":"2022","unstructured":"Ji E, Boerrigter D, Cai HQ, et al.. Peripheral complement is increased in schizophrenia and inversely related to cortical thickness. Brain Behav Immun. 2022, 101:423-34. 10.1016\/j.bbi.2021.11.014","journal-title":"Brain Behav Immun"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-49206-x","article-title":"Altered levels of cytokine, T- and B-lymphocytes, and PD-1 expression rates in drug-na\u00efve schizophrenia patients with acute phase","volume":"13","author":"Zheng Y","year":"2023","unstructured":"Zheng Y, Zhang Q, Zhou X, Yao L, Zhu Q, Fu Z. Altered levels of cytokine, T- and B-lymphocytes, and PD-1 expression rates in drug-na\u00efve schizophrenia patients with acute phase. Sci Rep. 2023, 13:21711. 10.1038\/s41598-023-49206-x","journal-title":"Sci Rep"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.4149\/BLL_2017_062","article-title":"Neutrophil-to-lymphocyte ratio. Sixteen-year-long history since publication of our article in Bratislava Medical Journal","volume":"118","author":"Zahorec R","year":"2017","unstructured":"Zahorec R. Neutrophil-to-lymphocyte ratio. Sixteen-year-long history since publication of our article in Bratislava Medical Journal. Bratisl Lek Listy. 2017, 118:321-3. 10.4149\/BLL_2017_062","journal-title":"Bratisl Lek Listy"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4149\/BLL_2021_078","article-title":"Neutrophil-to-lymphocyte ratio, past, present and future perspectives","volume":"122","author":"Zahorec R","year":"2021","unstructured":"Zahorec R. Neutrophil-to-lymphocyte ratio, past, present and future perspectives. Bratisl Lek Listy. 2021, 122:474-88. 10.4149\/BLL_2021_078","journal-title":"Bratisl Lek Listy"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-024-06330-w","article-title":"Neutrophil\/lymphocyte ratio is increased in the acute phase of schizophrenia and regardless the use and types of antipsychotic drugs","volume":"24","author":"Zheng Y","year":"2024","unstructured":"Zheng Y, Zhou X, Chen K, Fu Z, Zhang P, Zhu Q. Neutrophil\/lymphocyte ratio is increased in the acute phase of schizophrenia and regardless the use and types of antipsychotic drugs. BMC Psychiatry. 2024, 24:876. 10.1186\/s12888-024-06330-w","journal-title":"BMC Psychiatry"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2019.00996","article-title":"Elevated osteopontin and interferon gamma serum levels and increased neutrophil-to-lymphocyte ratio are associated with the severity of symptoms in schizophrenia","volume":"10","author":"Kov\u00e1cs M\u00c1","year":"2019","unstructured":"Kov\u00e1cs M\u00c1, T\u00e9nyi T, Kugyelka R, et al.. Elevated osteopontin and interferon gamma serum levels and increased neutrophil-to-lymphocyte ratio are associated with the severity of symptoms in schizophrenia. Front Psychiatry. 2019, 10:996. 10.3389\/fpsyt.2019.00996","journal-title":"Front Psychiatry"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/biom13020297","article-title":"The associations of neutrophil-lymphocyte, platelet-lymphocyte, monocyte-lymphocyte ratios and immune-inflammation index with negative symptoms in patients with schizophrenia","volume":"13","author":"\u0160agud M","year":"2023","unstructured":"\u0160agud M, Mad\u017earac Z, Nedic Erjavec G, et al.. The associations of neutrophil-lymphocyte, platelet-lymphocyte, monocyte-lymphocyte ratios and immune-inflammation index with negative symptoms in patients with schizophrenia. Biomolecules. 2023, 13:297. 10.3390\/biom13020297","journal-title":"Biomolecules"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2025.116604","article-title":"The relationship between inflammation and cognitive function in drug-na\u00efve schizophrenia with or without pre-metabolic syndrome","volume":"351","author":"Su Q","year":"2025","unstructured":"Su Q, Wang J, Ge H, et al.. The relationship between inflammation and cognitive function in drug-na\u00efve schizophrenia with or without pre-metabolic syndrome. Psychiatry Res. 2025, 351:116604. 10.1016\/j.psychres.2025.116604","journal-title":"Psychiatry Res"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/4040974","article-title":"The neutrophil-lymphocyte ratio is positively correlated with aggression in schizophrenia","volume":"2022","author":"Tong Z","year":"2022","unstructured":"Tong Z, Zhu J, Wang JJ, Yang YJ, Hu W. The neutrophil-lymphocyte ratio is positively correlated with aggression in schizophrenia. Biomed Res Int. 2022, 2022:4040974. 10.1155\/2022\/4040974","journal-title":"Biomed Res Int"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.4103\/ipj.ipj_6_25","article-title":"Association of neutrophil-to-lymphocyte ratio with antipsychotic administration in schizophrenia: a longitudinal study","volume":"34","author":"Raj R","year":"2025","unstructured":"Raj R, Dar SA, Wani ZA, Khare VK, Haq I. Association of neutrophil-to-lymphocyte ratio with antipsychotic administration in schizophrenia: a longitudinal study. Ind Psychiatry J. 2025, 34:108-13. 10.4103\/ipj.ipj_6_25","journal-title":"Ind Psychiatry J"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.sjpmh.2025.11.006","article-title":"Predictive value of C-reactive protein and hematologic ratios for metabolic syndrome in schizophrenia","volume":"Online ahead of print","author":"Sanchez-Autet M","year":"2026","unstructured":"Sanchez-Autet M, Alfonso M, Hernandez C, et al.. Predictive value of C-reactive protein and hematologic ratios for metabolic syndrome in schizophrenia. Span J Psychiatry Ment Health. 2026, Online ahead of print:10.1016\/j.sjpmh.2025.11.006","journal-title":"Span J Psychiatry Ment Health"},{"key":"ref16","unstructured":"World Health Organization. ICD-11 for mortality and morbidity statistics. 6A20 schizophrenia. Accessed: 2026: https:\/\/icd.who.int\/browse\/2026-01\/mms\/en#1683919430."},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/0165-1781(88)90038-8","article-title":"Reliability and validity of the positive and negative syndrome scale for schizophrenics","volume":"23","author":"Kay SR","year":"1988","unstructured":"Kay SR, Opler LA, Lindenmayer JP. Reliability and validity of the positive and negative syndrome scale for schizophrenics. Psychiatry Res. 1988, 23:99-110. 10.1016\/0165-1781(88)90038-8","journal-title":"Psychiatry Res"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2004.03.021","article-title":"A forced five-dimensional factor analysis and concurrent validity of the Positive and Negative Syndrome Scale in Mexican schizophrenic patients","volume":"72","author":"Fres\u00e1n A","year":"2005","unstructured":"Fres\u00e1n A, De la Fuente-Sandoval C, Loyzaga C, Garc\u00eda-Anaya M, Meyenberg N, Nicolini H, Apiquian R. A forced five-dimensional factor analysis and concurrent validity of the Positive and Negative Syndrome Scale in Mexican schizophrenic patients. Schizophr Res. 2005, 72:123-9. 10.1016\/j.schres.2004.03.021","journal-title":"Schizophr Res"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1186\/1745-0179-3-5","article-title":"Validity and reliability of the Functioning Assessment Short Test (FAST) in bipolar disorder","volume":"3","author":"Rosa AR","year":"2007","unstructured":"Rosa AR, S\u00e1nchez-Moreno J, Mart\u00ednez-Aran A, et al.. Validity and reliability of the Functioning Assessment Short Test (FAST) in bipolar disorder. Clin Pract Epidemiol Ment Health. 2007, 3:5. 10.1186\/1745-0179-3-5","journal-title":"Clin Pract Epidemiol Ment Health"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.rpsmen.2022.09.003","article-title":"Validity of the Functioning Assessment Short Tests (FAST), in patients with schizophrenia","volume":"15","author":"Luj\u00e1n-Lujan EM","year":"2022","unstructured":"Luj\u00e1n-Lujan EM, Garc\u00eda-Le\u00f3n M\u00c1, Rodriguez-Cano E, et al.. Validity of the Functioning Assessment Short Tests (FAST), in patients with schizophrenia. Rev Psiquiatr Salud Ment (Engl Ed). 2022, 15:157-66. 10.1016\/j.rpsmen.2022.09.003","journal-title":"Rev Psiquiatr Salud Ment (Engl Ed)"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/0920-9964(92)90003-N","article-title":"Reliability and validity of a depression rating scale for schizophrenics","volume":"6","author":"Addington D","year":"1992","unstructured":"Addington D, Addington J, Maticka-Tyndale E, Joyce J. Reliability and validity of a depression rating scale for schizophrenics. Schizophr Res. 1992, 6:201-8. 10.1016\/0920-9964(92)90003-N","journal-title":"Schizophr Res"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/S0920-9964(02)00490-5","article-title":"Cross-cultural adaptation and validation of the Spanish version of the Calgary Depression Scale for Schizophrenia","volume":"68","author":"Sarr\u00f3 S","year":"2004","unstructured":"Sarr\u00f3 S, Due\u00f1as RM, Ram\u0131\u0301rez N, et al.. Cross-cultural adaptation and validation of the Spanish version of the Calgary Depression Scale for Schizophrenia. Schizophr Res. 2004, 68:349-56. 10.1016\/S0920-9964(02)00490-5","journal-title":"Schizophr Res"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2023.01.042","article-title":"Anti-inflammatory effects of 2nd generation antipsychotics in patients with schizophrenia: a systematic review and meta-analysis","volume":"160","author":"Patlola SR","year":"2023","unstructured":"Patlola SR, Donohoe G, McKernan DP. Anti-inflammatory effects of 2nd generation antipsychotics in patients with schizophrenia: a systematic review and meta-analysis. J Psychiatr Res. 2023, 160:126-36. 10.1016\/j.jpsychires.2023.01.042","journal-title":"J Psychiatr Res"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1192\/j.eurpsy.2025.10063","article-title":"Peripheral inflammation and neurocognitive functioning in early psychosis: specific associations of TNF-\u03b1 and IL-6 with social cognition","volume":"68","author":"Catal\u00e1n A","year":"2025","unstructured":"Catal\u00e1n A, Aymerich C, Rodr\u00edguez-S\u00e1nchez JM, et al.. Peripheral inflammation and neurocognitive functioning in early psychosis: specific associations of TNF-\u03b1 and IL-6 with social cognition. Eur Psychiatry. 2025, 68:e95. 10.1192\/j.eurpsy.2025.10063","journal-title":"Eur Psychiatry"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2024.1444843","article-title":"Predictors of functioning in treatment-resistant schizophrenia: the role of negative symptoms and neurocognition","volume":"15","author":"Li Y","year":"2024","unstructured":"Li Y, Ang MS, Yee JY, See YM, Lee J. Predictors of functioning in treatment-resistant schizophrenia: the role of negative symptoms and neurocognition. Front Psychiatry. 2024, 15:1444843. 10.3389\/fpsyt.2024.1444843","journal-title":"Front Psychiatry"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13226959","article-title":"Internalised stigma, self-esteem and perceived social support as psychosocial predictors of quality of life in adult patients with schizophrenia","volume":"13","author":"Gagiu C","year":"2024","unstructured":"Gagiu C, Dionisie V, Manea MC, Mazilu DC, Manea M. Internalised stigma, self-esteem and perceived social support as psychosocial predictors of quality of life in adult patients with schizophrenia. J Clin Med. 2024, 13:6959. 10.3390\/jcm13226959","journal-title":"J Clin Med"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2022.893097","article-title":"Neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and monocyte-to-lymphocyte ratio in depression: an updated systematic review and meta-analysis","volume":"13","author":"Cheng Y","year":"2022","unstructured":"Cheng Y, Wang Y, Wang X, Jiang Z, Zhu L, Fang S. Neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and monocyte-to-lymphocyte ratio in depression: an updated systematic review and meta-analysis. Front Psychiatry. 2022, 13:893097. 10.3389\/fpsyt.2022.893097","journal-title":"Front Psychiatry"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S547916","article-title":"Inflammation promotes insulin resistance: analysis based on inflammation indices obtained from the complete blood count","volume":"18","author":"Zhang X","year":"2025","unstructured":"Zhang X, Wei Y, Wang Y, Wang G, Liu J. Inflammation promotes insulin resistance: analysis based on inflammation indices obtained from the complete blood count. J Inflamm Res. 2025, 18:16065-77. 10.2147\/JIR.S547916","journal-title":"J Inflamm Res"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1038\/s41537-025-00694-y","article-title":"Association between metabolic syndrome, diabetes mellitus, inflammation and cognitive dysfunctions in schizophrenia: a cross-sectional analysis","volume":"11","author":"Kancsev A","year":"2025","unstructured":"Kancsev A, Engh MA, Horv\u00e1th AA, Hegyi P, Kelemen O, K\u00e9ri S. Association between metabolic syndrome, diabetes mellitus, inflammation and cognitive dysfunctions in schizophrenia: a cross-sectional analysis. Schizophrenia (Heidelb). 2025, 11:148. 10.1038\/s41537-025-00694-y","journal-title":"Schizophrenia (Heidelb)"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.54.10.2939","article-title":"Tumor necrosis factor-alpha induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation","volume":"54","author":"Plomgaard P","year":"2005","unstructured":"Plomgaard P, Bouzakri K, Krogh-Madsen R, Mittendorfer B, Zierath JR, Pedersen BK. Tumor necrosis factor-alpha induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation. Diabetes. 2005, 54:2939-45. 10.2337\/diabetes.54.10.2939","journal-title":"Diabetes"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-10-119636","article-title":"IL6\/sIL6R complex contributes to emergency granulopoietic responses in G-CSF- and GM-CSF-deficient mice","volume":"111","author":"Walker F","year":"2008","unstructured":"Walker F, Zhang HH, Matthews V, et al.. IL6\/sIL6R complex contributes to emergency granulopoietic responses in G-CSF- and GM-CSF-deficient mice. Blood. 2008, 111:3978-85. 10.1182\/blood-2007-10-119636","journal-title":"Blood"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(19)30416-X","article-title":"Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: a systematic review and network meta-analysis","volume":"7","author":"Pillinger T","year":"2020","unstructured":"Pillinger T, McCutcheon RA, Vano L, et al.. Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: a systematic review and network meta-analysis. Lancet Psychiatry. 2020, 7:64-77. 10.1016\/S2215-0366(19)30416-X","journal-title":"Lancet Psychiatry"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/464438-association-of-peripheral-inflammatory-indices-with-symptom-severity-functioning-and-metabolic-parameters-in-the-mexican-population-diagnosed-with-schizophrenia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T14:36:57Z","timestamp":1775486217000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/464438-association-of-peripheral-inflammatory-indices-with-symptom-severity-functioning-and-metabolic-parameters-in-the-mexican-population-diagnosed-with-schizophrenia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,6]]},"references-count":32,"URL":"https:\/\/doi.org\/10.7759\/cureus.106527","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,6]]}}}